Benzodiazepines reported in NFLIS-Drug, 2015 to 2018
| Autor: | David C. Heller, Hope M. Smiley-McDonald, DeMia Pressley, Katherine Moore Bollinger, Belinda Weimer, Megan Grabenauer, Nichole Bynum |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Drug
medicine.medical_specialty medicine.drug_class media_common.quotation_subject Pathology and Forensic Medicine Heroin Benzodiazepines Drug trends Clonazolam medicine Psychiatry U.S. drug enforcement administration media_common Benzodiazepine K5000-5582 business.industry Clonazepam Criminal law and procedure Alprazolam National forensic laboratory information system Flubromazolam Interdisciplinary Forensics Etizolam business Law medicine.drug |
| Zdroj: | Forensic Science International: Synergy Forensic Science International: Synergy, Vol 3, Iss, Pp 100138-(2021) |
| ISSN: | 2589-871X |
| Popis: | The National Forensic Laboratory Information System (NFLIS) is a program of the U.S. Drug Enforcement Administration, Diversion Control Division. The NFLIS-Drug component collects drug identification results and associated information from drug cases submitted to and analyzed by federal, state, and local forensic laboratories. This paper presents national annual estimates and national and regional yearly trend differences for clonazepam, diazepam, flubromazolam, clonazolam, and etizolam using annual report rates per 100,000 persons aged 15 or older between 2015 and 2018. An estimated 263,538 benzodiazepine reports were identified by state and local laboratories between 2015 and 2018. Methamphetamine, cocaine, and heroin accounted for 32% of the drugs reported in the same item as alprazolam. Depressants and tranquilizers and narcotic analgesics were the drug classes most frequently identified in the same item as etizolam. A timeline of some benzodiazepines’ emergence in NFLIS-Drug is shown, as well as state- and county-level data for selected benzodiazepines. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|